![Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01620-6/MediaObjects/41416_2021_1620_Fig1_HTML.png)
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer
Dr. Archit Pandit - HIPEC - HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY❗️ Why HIPEC? Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a surgical process that's giving new hope to patients with abdominal cancers. Immediately after removing visible
![Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram](https://www.researchgate.net/publication/360554071/figure/fig1/AS:1155094594756618@1652407420502/Flow-diagram-GECOP-MMC-trial-PM-CC-peritoneal-metastases-from-colon-cancer-PCI.png)
Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram
![Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/050b3863-29ed-4b1f-b646-521e01bb61d4/gr1_lrg.gif)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology
![HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix](https://drmulier.com/hipec%20en%202.jpg)
HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix
![Exploring the Role of Hyperthermic Intraperitoneal Chemotherapy in Oligometastatic Colorectal Cancer to the Peritoneum Exploring the Role of Hyperthermic Intraperitoneal Chemotherapy in Oligometastatic Colorectal Cancer to the Peritoneum](https://dailynews.ascopubs.org/do/10.1200/ADN.22.201086/full/dn22_ee_grotz_table_thumbnail-1658903949819.png)
Exploring the Role of Hyperthermic Intraperitoneal Chemotherapy in Oligometastatic Colorectal Cancer to the Peritoneum
![JCM | Free Full-Text | Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies JCM | Free Full-Text | Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies](https://pub.mdpi-res.com/jcm/jcm-11-02840/article_deploy/html/images/jcm-11-02840-g001.png?1652856477)
JCM | Free Full-Text | Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Perito
![Frontiers | Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review Frontiers | Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review](https://www.frontiersin.org/files/MyHome%20Article%20Library/795390/795390_Thumb_400.jpg)
Frontiers | Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review
![Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin](https://www.frontiersin.org/files/Articles/1122755/fonc-13-1122755-HTML-r1/image_m/fonc-13-1122755-g001.jpg)
Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma
![HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2021/12/17/16/35/hipec-mc1crmd-767wx535h.jpg)
HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic
![Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - ScienceDirect Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0748798320306673-gr1.jpg)
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - ScienceDirect
![JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer](https://www.mdpi.com/jcm/jcm-12-06443/article_deploy/html/images/jcm-12-06443-g001.png)